Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Ferrari

Showing results (431-440 of 500) with videos related to

Pageof 50
Sort By:
The Lancet. Oncology|September 29, 2019
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trialGianni Bisogno, Gian Luca De Salvo, Christophe Bergeron, et al.
Cancer Medicine|March 23, 2023
Long-term survivors with desmoplastic small round cell tumor (DSRCT): Results from a retrospective single-institution case series analysisClaudia Giani, Stefano Radaelli, Rosalba Miceli, et al.
Elife|March 18, 2016
Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypesDeborah Morena, Nicola Maestro, Francesca Bersani, et al.
Oncotarget|July 8, 2016
Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcomaPatrizia Gasparini, Michela Casanova, Raffaella Villa, et al.
Pediatric Blood & Cancer|May 22, 2018
Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groupsVeronique Minard-Colin, David Walterhouse, Gianni Bisogno, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2025
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 resultsAnnalisa Trama, Paolo Lasalvia, Dan Stark, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2025
NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT)Tim Flaadt, Lauriane Lemelle, Michael Abele, et al.
Pediatric Blood & Cancer|July 14, 2021
Role of centers with different patient volumes in the management of rhabdomyosarcoma. An analysis by the Italian Pediatric Soft Tissue Sarcoma CommitteeGianni Bisogno, Giovanna Congiu, Maria Carmen Affinita, et al.
Pediatric Blood & Cancer|January 20, 2018
Pediatric patients with cutaneous melanoma: A European studyInes B Brecht, Angela De Paoli, Gianni Bisogno, et al.
Cancer|July 26, 2024
Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trialHenry C Mandeville, Gianni Bisogno, Veronique Minard-Colin, et al.
Pageof 50

Showing results (431-440 of 500) with videos related to

Sort By:
Pageof 50
The Lancet. Oncology|September 29, 2019
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trialGianni Bisogno, Gian Luca De Salvo, Christophe Bergeron, et al.
Cancer Medicine|March 23, 2023
Long-term survivors with desmoplastic small round cell tumor (DSRCT): Results from a retrospective single-institution case series analysisClaudia Giani, Stefano Radaelli, Rosalba Miceli, et al.
Elife|March 18, 2016
Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypesDeborah Morena, Nicola Maestro, Francesca Bersani, et al.
Oncotarget|July 8, 2016
Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcomaPatrizia Gasparini, Michela Casanova, Raffaella Villa, et al.
Pediatric Blood & Cancer|May 22, 2018
Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groupsVeronique Minard-Colin, David Walterhouse, Gianni Bisogno, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2025
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 resultsAnnalisa Trama, Paolo Lasalvia, Dan Stark, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2025
NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT)Tim Flaadt, Lauriane Lemelle, Michael Abele, et al.
Pediatric Blood & Cancer|July 14, 2021
Role of centers with different patient volumes in the management of rhabdomyosarcoma. An analysis by the Italian Pediatric Soft Tissue Sarcoma CommitteeGianni Bisogno, Giovanna Congiu, Maria Carmen Affinita, et al.
Pediatric Blood & Cancer|January 20, 2018
Pediatric patients with cutaneous melanoma: A European studyInes B Brecht, Angela De Paoli, Gianni Bisogno, et al.
Cancer|July 26, 2024
Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trialHenry C Mandeville, Gianni Bisogno, Veronique Minard-Colin, et al.
Pageof 50